Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect micePhillip Pymm, Wai‐Hong Tham, Ester López et al.|Proceedings of the National Academy of Sciences|2021Cited by 165
Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domainAdam K. Wheatley, Wai‐Hong Tham, Phillip Pymm et al.|Cell Reports|2021Cited by 80
Biparatopic nanobodies targeting the receptor binding domain efficiently neutralize SARS-CoV-2Phillip Pymm, Nicholas A. Gherardin, Samuel J. Redmond et al.|iScience|2022Cited by 19